1.
Authors' reply to comment on "Cost-effectiveness analysis of Herpes Zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts: a comparison between no vaccination, th...
2.
3.
4.
5.
Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression
6.
7.
8.
9.
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine,...
Cost-effectiveness analysis of herpes zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts : a comparison between no vaccination, the adjuvanted subunit vaccine,...
Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting?
Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Aty...
COVID-19 and retail : the catalyst for e-commerce in Belgium?
Ontwikkeling van een beslismodel ter ondersteuning van prioriteitenstelling m.b.t. vaccinatieprogramma’s in Vlaanderen ; Development of a decision model to prioritise vaccination p...
Evidence-based prevention of cannabis use in Flanders: is there a role for health economic evaluation?
Ontwikkeling van een beslismodel ter ondersteuning van prioriteitenstelling m.b.t. vaccinatieprogramma's in Vlaanderen